![](/img/cover-not-exists.png)
TCT-826 Prospective single center First In Human (FIH) clinical trial to evaluate the safety and effectiveness of a septal occluder with bioresorbable framework in patients with clinically significant atrial septum defect (ASD) or patent foramen ovale (PFO)
Söderberg, Björn, Vaskelyte, Laura, Sievert, Kolja, Gafoor, Sameer, Hofmann, Ilona, Mellmann, Andreas, Bernhard, Jerome, Sievert, HorstVolume:
68
Language:
english
Journal:
Journal of the American College of Cardiology
DOI:
10.1016/j.jacc.2016.09.855
Date:
November, 2016
File:
PDF, 179 KB
english, 2016